AMN Healthcare price target lowered to $83 from $85 at BMO Capital

BMO Capital analyst Jeffrey Silber lowered the firm’s price target on AMN Healthcare to $83 from $85 and keeps an Outperform rating on the shares. Challenged environment around a returning to normal seasonality in Nurse and Allied still persists, and while investor interest on this name has been increasing, trends are still weakening, the analyst tells investors in a research note.